Table 1

Baseline demographic characteristics of study participants with and without follow-up

Baseline data in all study participants (n = 10,370)Baseline data in patients with follow-up (n = 3,182)
Age (years) 38.0 (±18.8) 39.5 (±19.6) 
Sex, females 5,322 (51) 1,688 (53) 
Baseline BMI (kg/m225.2 (±6.4) 25.1 (±6.2) 
Duration of diabetes (years) 16.0 (±49.9) 17 0.1 (±15.5) 
Type 1 diabetes 10,058 (97) 3,126 (98) 
Insulin pump 2,428 (23) 862 (27) 
White Caucasians 8,524 (82) 2,713 (88) 
NHS funded 7,602 (73) 2,354 (74) 
Number of test strips used per day 7.7 (±9.8) 8.1 (±10.1) 
Mean pre-FSL HbA1c (mmol/mol) 69.8 (±18.2) 67.5 (±20.9) 
Baseline Gold score 2.7 (±1.8) 2.7 (±1.9) 
Completion of structured education 6,764 (65) 2,002 (65) 
Baseline data in all study participants (n = 10,370)Baseline data in patients with follow-up (n = 3,182)
Age (years) 38.0 (±18.8) 39.5 (±19.6) 
Sex, females 5,322 (51) 1,688 (53) 
Baseline BMI (kg/m225.2 (±6.4) 25.1 (±6.2) 
Duration of diabetes (years) 16.0 (±49.9) 17 0.1 (±15.5) 
Type 1 diabetes 10,058 (97) 3,126 (98) 
Insulin pump 2,428 (23) 862 (27) 
White Caucasians 8,524 (82) 2,713 (88) 
NHS funded 7,602 (73) 2,354 (74) 
Number of test strips used per day 7.7 (±9.8) 8.1 (±10.1) 
Mean pre-FSL HbA1c (mmol/mol) 69.8 (±18.2) 67.5 (±20.9) 
Baseline Gold score 2.7 (±1.8) 2.7 (±1.9) 
Completion of structured education 6,764 (65) 2,002 (65) 

Data are mean (±SD) or n (%).

Close Modal

or Create an Account

Close Modal
Close Modal